Contract development and manufacturing organisation (CDMO) Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia. The company achieved this cGMP certification following an inspection by the Federal State Institution ‘State Institute of Drugs and Good Practices’ of Russia.
With over 70 years of opiate fully backward integrated production we can guarantee the highest quality and full control over the final product delivered to our customers.More Info
Contract development and manufacturing organization (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1.5 million grant from the Slovak Ministry of Education, Science, Research and Sport.
Pelletisation can offer considerable advantages when it comes to drug delivery, particularly for controlled or delayed release of oral formulations. It can also reduce the risk of dose dumping, adverse side effects and irritation in the gastro-intestinal (GI) tract.